Skip to content

Clinical trials

Terminated Neoplasm Metastasis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Terminated Country / region: South Korea Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20081
20091
20101
20122
20133
20143
20151
20161
20172
20182
20195
20204
20215
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Clovis Oncology, Inc.3
Odonate Therapeutics, Inc.3
AstraZeneca2
BeiGene2
National Cancer Center, Korea2
Turning Point Therapeutics, Inc.2
Ascendis Pharma Oncology Division A/S1
Biomea Fusion Inc.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis37
Carcinoma, Non-Small-Cell Lung13
Neoplasms9
Breast Neoplasms8
Colorectal Neoplasms8
Recurrence5
Lung Neoplasms4
Cholangiocarcinoma2
Head and Neck Neoplasms2
Melanoma2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.